Nemucore Medical Innovations
Glioblastoma is a heterogeneous disease such that the receptors expressed vary based on tumor location. Working with Nemucore Medical Innovations, Inc., theranostic nanoemulsions were designed and manufactured to combat Glioblastoma and other brain diseases. Engineered targeting ligands incorporated in the nanoemulsions assisted in delivery to specific regions. Magnetic Resonance Imaging determined the bio-distribution in healthy rats across the Blood-Brain Barrier. Statistical analysis was completed with T1 MRI data for 174 defined regions. A 3-dimensional heat map program was created to integrate MRI imaging and statistical analysis. In conclusion, data demonstrates targeting ligands on the nanoemulsions alter pharmacodynamics in rat brains, shown by a fully integrated imaging system.
Worcester Polytechnic Institute
Major Qualifying Project
All authors have granted to WPI a nonexclusive royalty-free license to distribute copies of the work, subject to other agreements. Copyright is held by the author or authors, with all rights reserved, unless otherwise noted.